✨
AI Summary
- Balaji Srinivasan criticizes the FDA's broken drug approval process and its human cost
- He declined a position in Trump's FDA, questioning whether dismantling the administrative state requires one decisive action or sustained 'island hopping'
- Examination of systemic government dysfunction and implications for reforming federal institutions
Guests on This Episode
BS
Balaji Srinivasan
4 podcast appearances